Clinical characteristics and outcome in dogs with small cell T-cell intestinal lymphoma

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Small cell intestinal lymphoma has not been well characterized in dogs. The objective of this study was to describe clinical characteristics and outcome in dogs with small cell intestinal lymphoma. We hypothesized that affected dogs would have prolonged survival compared with high-grade gastrointestinal (GI) lymphoma. Pathology records were searched for dogs with histologically confirmed small cell GI lymphoma. Seventeen dogs with confirmed small cell intestinal lymphoma were identified, and clinical and outcome data were retrospectively collected. Histopathology was reviewed by a board-certified pathologist, and tissue sections were subjected to immunophenotyping and molecular clonality assessment. All dogs had small cell, T-cell, lymphoma confirmed within various regions of small intestine, with 1 dog also having disease in abdominal lymph nodes. All dogs had clinical signs attributable to GI disease; diarrhoea (n=13) was most common. Ultrasonographic abnormalities were present in 8 of 13 dogs with abnormal wall layering (n=7) and hyperechoic mucosal striations (n=7) representing the most common findings. In total, 14 dogs received some form of treatment. The median survival time (MST) for all dogs was 279 days and the MST for the 14 dogs that received any treatment was 628 days. Dogs with anaemia and weight loss at presentation had significantly shorter survival times and dogs that received a combination of steroids and an alkylating agent had significantly longer survival times. Small cell, T-cell, intestinal lymphoma is a distinct disease process in dogs, and those undergoing treatment may experience prolonged survival.

Original languageEnglish (US)
JournalVeterinary and Comparative Oncology
DOIs
StateAccepted/In press - Jan 1 2018

Fingerprint

T-Cell Lymphoma
lymphoma
T-lymphocytes
Dogs
dogs
cells
B-Cell Chronic Lymphocytic Leukemia
Immunophenotyping
Gastrointestinal Diseases
Alkylating Agents
digestive system diseases
histopathology
Non-Hodgkin's Lymphoma
anemia
Small Intestine
steroids
lymph nodes
small intestine

Keywords

  • Alimentary
  • Canine
  • Clonality
  • Indolent
  • Low-grade

ASJC Scopus subject areas

  • veterinary(all)

Cite this

@article{1683a7fcca594e95a2450ea6f9120d65,
title = "Clinical characteristics and outcome in dogs with small cell T-cell intestinal lymphoma",
abstract = "Small cell intestinal lymphoma has not been well characterized in dogs. The objective of this study was to describe clinical characteristics and outcome in dogs with small cell intestinal lymphoma. We hypothesized that affected dogs would have prolonged survival compared with high-grade gastrointestinal (GI) lymphoma. Pathology records were searched for dogs with histologically confirmed small cell GI lymphoma. Seventeen dogs with confirmed small cell intestinal lymphoma were identified, and clinical and outcome data were retrospectively collected. Histopathology was reviewed by a board-certified pathologist, and tissue sections were subjected to immunophenotyping and molecular clonality assessment. All dogs had small cell, T-cell, lymphoma confirmed within various regions of small intestine, with 1 dog also having disease in abdominal lymph nodes. All dogs had clinical signs attributable to GI disease; diarrhoea (n=13) was most common. Ultrasonographic abnormalities were present in 8 of 13 dogs with abnormal wall layering (n=7) and hyperechoic mucosal striations (n=7) representing the most common findings. In total, 14 dogs received some form of treatment. The median survival time (MST) for all dogs was 279 days and the MST for the 14 dogs that received any treatment was 628 days. Dogs with anaemia and weight loss at presentation had significantly shorter survival times and dogs that received a combination of steroids and an alkylating agent had significantly longer survival times. Small cell, T-cell, intestinal lymphoma is a distinct disease process in dogs, and those undergoing treatment may experience prolonged survival.",
keywords = "Alimentary, Canine, Clonality, Indolent, Low-grade",
author = "Couto, {K. M.} and Moore, {Peter F} and Allison Zwingenberger and Jennifer Willcox and Skorupski, {Katherine A}",
year = "2018",
month = "1",
day = "1",
doi = "10.1111/vco.12384",
language = "English (US)",
journal = "Veterinary and Comparative Oncology",
issn = "1476-5829",
publisher = "Wiley-Blackwell",

}

TY - JOUR

T1 - Clinical characteristics and outcome in dogs with small cell T-cell intestinal lymphoma

AU - Couto, K. M.

AU - Moore, Peter F

AU - Zwingenberger, Allison

AU - Willcox, Jennifer

AU - Skorupski, Katherine A

PY - 2018/1/1

Y1 - 2018/1/1

N2 - Small cell intestinal lymphoma has not been well characterized in dogs. The objective of this study was to describe clinical characteristics and outcome in dogs with small cell intestinal lymphoma. We hypothesized that affected dogs would have prolonged survival compared with high-grade gastrointestinal (GI) lymphoma. Pathology records were searched for dogs with histologically confirmed small cell GI lymphoma. Seventeen dogs with confirmed small cell intestinal lymphoma were identified, and clinical and outcome data were retrospectively collected. Histopathology was reviewed by a board-certified pathologist, and tissue sections were subjected to immunophenotyping and molecular clonality assessment. All dogs had small cell, T-cell, lymphoma confirmed within various regions of small intestine, with 1 dog also having disease in abdominal lymph nodes. All dogs had clinical signs attributable to GI disease; diarrhoea (n=13) was most common. Ultrasonographic abnormalities were present in 8 of 13 dogs with abnormal wall layering (n=7) and hyperechoic mucosal striations (n=7) representing the most common findings. In total, 14 dogs received some form of treatment. The median survival time (MST) for all dogs was 279 days and the MST for the 14 dogs that received any treatment was 628 days. Dogs with anaemia and weight loss at presentation had significantly shorter survival times and dogs that received a combination of steroids and an alkylating agent had significantly longer survival times. Small cell, T-cell, intestinal lymphoma is a distinct disease process in dogs, and those undergoing treatment may experience prolonged survival.

AB - Small cell intestinal lymphoma has not been well characterized in dogs. The objective of this study was to describe clinical characteristics and outcome in dogs with small cell intestinal lymphoma. We hypothesized that affected dogs would have prolonged survival compared with high-grade gastrointestinal (GI) lymphoma. Pathology records were searched for dogs with histologically confirmed small cell GI lymphoma. Seventeen dogs with confirmed small cell intestinal lymphoma were identified, and clinical and outcome data were retrospectively collected. Histopathology was reviewed by a board-certified pathologist, and tissue sections were subjected to immunophenotyping and molecular clonality assessment. All dogs had small cell, T-cell, lymphoma confirmed within various regions of small intestine, with 1 dog also having disease in abdominal lymph nodes. All dogs had clinical signs attributable to GI disease; diarrhoea (n=13) was most common. Ultrasonographic abnormalities were present in 8 of 13 dogs with abnormal wall layering (n=7) and hyperechoic mucosal striations (n=7) representing the most common findings. In total, 14 dogs received some form of treatment. The median survival time (MST) for all dogs was 279 days and the MST for the 14 dogs that received any treatment was 628 days. Dogs with anaemia and weight loss at presentation had significantly shorter survival times and dogs that received a combination of steroids and an alkylating agent had significantly longer survival times. Small cell, T-cell, intestinal lymphoma is a distinct disease process in dogs, and those undergoing treatment may experience prolonged survival.

KW - Alimentary

KW - Canine

KW - Clonality

KW - Indolent

KW - Low-grade

UR - http://www.scopus.com/inward/record.url?scp=85040636838&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85040636838&partnerID=8YFLogxK

U2 - 10.1111/vco.12384

DO - 10.1111/vco.12384

M3 - Article

C2 - 29322604

AN - SCOPUS:85040636838

JO - Veterinary and Comparative Oncology

JF - Veterinary and Comparative Oncology

SN - 1476-5829

ER -